Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
LETTER TO THE EDITOR
Real-world treatment chronic migraine in Poland
1
Department of Neurology, Faculty of Medicine and Dentistry, Medical University of Warsaw, Bielanski Hospital, Warsaw, Poland
2
Department of Adult Neurology, Medical University of Gdansk, University Clinical Centre, Gdansk, Poland
3
Department of Neurology, Military Institute of Medicine, Warsaw, Poland
These authors had equal contribution to this work
Submission date: 2024-11-28
Acceptance date: 2024-12-12
Online publication date: 2024-12-31
Corresponding author
Izabela Domitrz
Department of Neurology Faculty of Medicine and Dentistry Medical University Bielanski Hospital Warsaw, Poland
Department of Neurology Faculty of Medicine and Dentistry Medical University Bielanski Hospital Warsaw, Poland
TOPICS
REFERENCES (11)
1.
GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396: 1204-22. Erratum in: Lancet 2020; 396: 1562.
2.
Stovner LJ, Hagen K, Linde M, et al. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 2022; 23: 34.
3.
Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 2017; 372: 307-15.
4.
Buse DC, Fanning KM, Reed ML, et al. Life with migraine: effects on relationships, career, and finances from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache 2019; 59: 1286-99.
5.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38: 1-211.
6.
Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet 2021; 397: 1485-95.
7.
www.nfz.gov.pl/zarzadzenia-prezesa/uchwaly-rady-nfz/uchwala-nr-292024iv,6679.html.
9.
Domitrz I, Kozubski W, Rożniecki J, Stępień A, Boczarska-Jedynak M. The Polish Headache Society and the Headache Section of the Polish Neurological Society Consensus Statement: update on new pharmacological therapies for migraine in clinical practice and public medication reimbursement program for chronic migraine. Arch Med Sci 2022; 18: 1705-7.
10.
Domitrz I, Kozubski W, Stępień A, et al. The Polish Experts’ Consensus Statement: 2023 Update on new therapies for migraine. Arch Med Sci 2024; 20: 339-43.
11.
Stępień A, Kozubski W, Rożniecki J, Domitrz I. Rozpoznawanie i leczenie migreny 2024 – aktualizacja rekomendacji – opracowanie Grupy Ekspertów Sekcji Bólu Głowy Polskiego Towarzystwa Neurologicznego i Polskiego Towarzystwa Badania Bólu. Ból 2024; 25: 9-33.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
